- Home
- EDSA vs EVAX Comparison
EDSA vs EVAX Comparison
Compare EDSA & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- EVAX
- Stock Information
- Founded
- EDSA 2015
- EVAX 2008
- Country
- EDSA Canada
- EVAX Denmark
- Employees
- EDSA N/A
- EVAX N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EDSA Health Care
- EVAX Health Care
- Exchange
- EDSA Nasdaq
- EVAX Nasdaq
- Market Cap
- EDSA 17.5M
- EVAX 17.8M
- IPO Year
- EDSA N/A
- EVAX 2021
- Fundamental
- Price
- EDSA $2.72
- EVAX $6.29
- Analyst Decision
- EDSA Strong Buy
- EVAX Strong Buy
- Analyst Count
- EDSA 2
- EVAX 2
- Target Price
- EDSA $13.00
- EVAX $11.00
- AVG Volume (30 Days)
- EDSA 121.9K
- EVAX 4.4M
- Earning Date
- EDSA 08-08-2025
- EVAX 10-30-2025
- Dividend Yield
- EDSA N/A
- EVAX N/A
- EPS Growth
- EDSA N/A
- EVAX N/A
- EPS
- EDSA N/A
- EVAX N/A
- Revenue
- EDSA N/A
- EVAX $3,176,000.00
- Revenue This Year
- EDSA N/A
- EVAX N/A
- Revenue Next Year
- EDSA N/A
- EVAX $425.50
- P/E Ratio
- EDSA N/A
- EVAX N/A
- Revenue Growth
- EDSA N/A
- EVAX 1042.45
- 52 Week Low
- EDSA $1.55
- EVAX $1.20
- 52 Week High
- EDSA $4.49
- EVAX $15.50
- Technical
- Relative Strength Index (RSI)
- EDSA 62.87
- EVAX 67.86
- Support Level
- EDSA $2.47
- EVAX $3.70
- Resistance Level
- EDSA $2.82
- EVAX $7.23
- Average True Range (ATR)
- EDSA 0.18
- EVAX 0.66
- MACD
- EDSA 0.03
- EVAX 0.27
- Stochastic Oscillator
- EDSA 85.46
- EVAX 70.78
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.